Anagnostics, Molzym Co-developing System to ID Sepsis Pathogens | GenomeWeb

NEW YORK (GenomeWeb News) – Anagnostics and Molzym today announced a licensing agreement and partnership to develop hybcell Pathogens DNA, a system for the rapid identification of sepsis-causing pathogens from whole blood.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.